Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy — NEURISK  

Non-hematologic Cancer Clinical Trial

Official title: Predictive Models of Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy.

Status Completed

Clinical Trial Summary

The purpose of this study is to identify prognostic factors and to develop predictive models of risk of febrile neutropenia and neutropenia grade 3/4 in patients with solid tumors receiving chemotherapy with schemas that have an inherent risk of febrile neutropenia of 10-20%.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Febrile Neutropenia
• Neutropenia
• Non-hematologic Cancer

• NCT number: NCT01799421
• Study type: Observational
• Source: Asociación para el Fomento de la Investigación y el Desarrollo Integral de la Oncología
• Status: Completed
• Phase: N/A
• Start date: October 2011
• Completion date: December 2015